|
Volumn 358, Issue 9287, 2001, Pages 1029-1030
|
Is LBP-1c/CP2/LSF a disease-modifying gene for Alzheimer's disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACUTE PHASE PROTEIN;
ALPHA 2 MACROGLOBULIN;
AMYLOID BETA PROTEIN;
AMYLOID PRECURSOR PROTEIN;
APOLIPOPROTEIN E;
APOLIPOPROTEIN E4;
GENE PRODUCT;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 1ALPHA;
LOW DENSITY LIPOPROTEIN RECEPTOR;
LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;
NUCLEAR TRANSCRIPTION FACTOR;
SYNAPTOTAGMIN;
TAU PROTEIN;
TRANSCRIPTION FACTOR;
UNCLASSIFIED DRUG;
ALLELE;
ALZHEIMER DISEASE;
CHROMOSOME 12;
CLEARANCE;
DNA POLYMORPHISM;
GENE CONTROL;
GENE EXPRESSION;
GENETIC DISORDER;
GENETIC LINKAGE;
HERPES SIMPLEX VIRUS 1;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
LYMPHOCYTE;
NEUROBLASTOMA;
NEUROBLASTOMA CELL;
NEUROPATHOLOGY;
NOTE;
ONSET AGE;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN VARIANT;
RISK FACTOR;
VIRUS;
|
EID: 0035968635
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(01)06228-6 Document Type: Note |
Times cited : (10)
|
References (12)
|